Nomura Asset Management Co. Ltd. lowered its holdings in Solventum Co. (NYSE:SOLV - Free Report) by 21.9% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,441 shares of the company's stock after selling 12,498 shares during the period. Nomura Asset Management Co. Ltd.'s holdings in Solventum were worth $3,098,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. SG Americas Securities LLC acquired a new stake in shares of Solventum in the 2nd quarter worth about $823,000. Sequoia Financial Advisors LLC bought a new stake in Solventum during the second quarter worth approximately $280,000. Wealth Enhancement Advisory Services LLC acquired a new position in shares of Solventum in the 2nd quarter worth $2,072,000. ORG Partners LLC purchased a new position in Solventum in the 2nd quarter worth about $40,000. Finally, Envestnet Portfolio Solutions Inc. acquired a new stake in shares of Solventum during the second quarter valued at approximately $491,000.
Solventum Stock Down 0.6 %
Shares of SOLV traded down $0.45 during trading hours on Friday, hitting $69.56. The stock had a trading volume of 637,853 shares, compared to its average volume of 824,329. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05. The company's fifty day moving average is $70.91 and its two-hundred day moving average is $63.24.
Analyst Ratings Changes
SOLV has been the subject of several research analyst reports. Mizuho initiated coverage on Solventum in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $70.00 price objective for the company. Wolfe Research assumed coverage on Solventum in a report on Thursday, September 26th. They issued a "peer perform" rating for the company. BTIG Research initiated coverage on shares of Solventum in a report on Thursday, September 5th. They set a "neutral" rating for the company. Morgan Stanley increased their price objective on Solventum from $60.00 to $73.00 and gave the company an "equal weight" rating in a research report on Monday, November 11th. Finally, Stifel Nicolaus initiated coverage on shares of Solventum in a research note on Tuesday, October 8th. They issued a "buy" rating and a $82.00 target price for the company. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $68.29.
View Our Latest Analysis on SOLV
Solventum Profile
(
Free Report)
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Recommended Stories
Before you consider Solventum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solventum wasn't on the list.
While Solventum currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
